The abstract is read at the publisher; the summary is JClub's.
APOE alleles account for most late-onset Alzheimer’s disease burden, with the ε3 allele increasing risk versus ε2 and ε3/ε4 together explaining the majority in populations with reliable data.
- Why it matters: The overall contribution of APOE to Alzheimer’s disease burden may be underestimated because the risk effect of the most common ε3 allele relative to ε2 is not always recognized.
- What they did: The authors synthesize epidemiological evidence across late-onset European-ancestry populations and other ethnic groups with reliable data, incorporating effects of ε3 and ε4 and considering sporadic early-onset and mutation- or trisomy 21–linked cases.
- The result: The combined evidence suggests APOE is a predominant cause spanning multiple Alzheimer’s etiologies, implying that therapies modulating APOE’s role could benefit almost all prospective Alzheimer’s cases.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.